Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy

Lancet

Volumn 349, Issue 9058, 1997, Pages 1063-1065

  Söderlund, Maria ^c   Von Essen, Robert ^a   Haapasaari, Jarkko ^a   Kiistala, Urpo ^b   Kiviluoto, Olli ^b   Hedman, Klaus ^c  

^a RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^b CENTRAL MILITARY HOSPITAL   (Finland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ARTHROPATHY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PARVOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYNOVIUM; VIRUS INFECTION;

EID: 0342684461     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)09110-6     Document Type: Article

References (24)

1. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985; i: 419-21.
2. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1985; i: 422-25.
3. Naides SJ. Parvovirus B19 infection. Rheum Dis Clin North Am 1993; 19: 457-75.
4. Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993; 167: 744-48.
5. Dijkmans BA, van Elsacker-Niele AM, Salimans MM, van Albada-Kupiers GA, de Vries E, Weiland HT. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 1988; 31: 279-81.
6. Saal JG, Steidle M, Einsele H, Müller CA, Fritz P, Zacher J. Persistence of B19 parovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992; 12: 147-51.
7. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliot JR, Mollan RA. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995; 34: 809-13.
8. Nikkari S, Roivainen A, Hannonen P, et al. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995; 54: 597-600.
9. Söderlund M, Ruutu P, Ruutu T , Asikainen K, Franssila R, Hedman K. Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis 1997; 29: 129-35.
10. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from a child during aplastic crisis. J Virol 1986; 58: 921-36.
11. Anderson MJ, Davis LR, Hodgson J, et al. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol 1982; 35: 744-49.
12. Brown CS, Salimans MM, Noteborn MH, Weiland HT. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res 1990; 15: 197-212.
13. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995; 171: 710-13.
14. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol 1993; 4: 123-29.
15. Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995; 172: 1431-36.
16. Woolf AD, Cohen BJ. Parvovirus B19 and chronic arthritis - causal or casual association? Ann Rheum Dis 1995; 54: 535-36.
17. Franssila R, Söderlund M, Brown C, Spaan W, Seppälä I, Hedman K. IgG subclass response to human parvovirus B19 infection. Clin Diagn Virol 1996; 6: 41-49.
18. Linde A, Sundqvist VA, Mathiesen T, Wahren B. IgG subclasses to subviral components. Monogr Allergy 1988; 23: 27-32.
19. Taylor HG, Borg AA, Dawes PT. Human parvovirus B19 and rheumatoid arthritis. Clin Rheumatol 1992; 11: 548-50.
20. von Poblotzki A, Hemauer A, Gigler A, et al. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis 1995; 172: 1356-59.
21. Edwards JCW. The nature and origins of synovium: experimental approaches to the study of synoviocyte differentiation. J Anat 1994; 184: 493-501.
22. Brown KE, Anderson SM, Young NS. Erthrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-17.
23. Miki NP, Chantler JK. Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro. J Gen Virol 1992; 73: 1559-62.
24. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87: 2211-15.